Vanguard Group Inc. Sells 35,436 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Vanguard Group Inc. reduced its holdings in Henry Schein, Inc. by 0.2%, owning approximately 11.99% of the company after selling 35,436 shares, valuing its total stake at over $1 billion.
• Several hedge funds have either increased or established new positions in Henry Schein, highlighting significant interest from institutional investors, who own 96.62% of the company's stock.
• Analysts have recently adjusted their price targets for Henry Schein, with most ratings trending towards a "hold", reflecting cautious sentiment in light of its recent miss in quarterly earnings estimates.

Vanguard Group Inc. reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,690,082 shares of the company's stock after selling 35,436 shares during the quarter. Vanguard Group Inc. owned 11.99% of Henry Schein worth $1,006,124,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Investment Management Corp VA ADV acquired a new position in Henry Schein during the fourth quarter valued at approximately $32,000. Rakuten Securities Inc. acquired a new stake in shares of Henry Schein in the first quarter valued at approximately $34,000. Whittier Trust Co. increased its stake in shares of Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares during the period. UMB Bank n.a. increased its stake in shares of Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Finally, Allworth Financial LP increased its stake in shares of Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Up 0.0%

Henry Schein stock traded up $0.03 during midday trading on Friday, reaching $67.94. The stock had a trading volume of 848,305 shares, compared to its average volume of 1,770,881. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a market capitalization of $8.24 billion, a P/E ratio of 21.92, a PEG ratio of 2.28 and a beta of 0.81. The company has a fifty day moving average price of $70.86 and a two-hundred day moving average price of $70.90. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the firm earned $1.23 earnings per share. The business's quarterly revenue was up 3.3% on a year-over-year basis. As a group, equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HSIC shares. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Piper Sandler reduced their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Barrington Research reduced their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Finally, Evercore ISI reduced their target price on Henry Schein from $78.00 to $70.00 and set an "in-line" rating on the stock in a report on Wednesday, August 6th. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $75.58.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.